Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline plus Colistin for MDR A. baumannii Infection
NCT05586815Phase 4Unknown
- Sponsor
- Mahidol University
- Start
- Jan 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Acinetobacter baumannii infection comparing Colistin plus Placebo with Colistin plus Minocycline (2 arms). Primary endpoint: All cause mortality at 28 days. Status: unknown.
02
Drugs
minocycline
03
Conditions
Acinetobacter baumannii infection
Beyond the preview
Go deeper on NCT05586815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05586815.